Featured post

A walk in the Park

This blog is dedicated to everyone who has struggled with Community Medicine. Through my posts I hope to simplify and demystify community medicine. The emphasis will be on clarifying concepts rather than providing ready-made answers to exam questions.

Feedback is crucial for the success of this endeavour, so you are encouraged to comment and criticize if you cannot understand something.

If you want a topic to be discussed sooner rather than later, please let me know via

Facebook: http://www.facebook.com/pages/Community-Medicine-for-ASSES/429533760433198  

[Alternatively, you may join the group communitymedicine4asses: 


Twitter: @DocRoopesh

In addition, you could take a short survey to help improve this blog:


A single example may not be able to explain 100% of a given topic, so multiple examples may be provided to explain different parts of a single concept.

If something doesn’t seem right:

a. Write to me about it (at communitymedicine4asses@yahoo.com), and

b. Cross check with another source (textbook, expert, etc.)

I hope that my exertions will make your experience with community medicine seem like a “Walk in the Park”

Note 1. Those who wish to contact me on facebook are requested to kindly send a personal message introducing themselves along with the request. This will help save time and effort of all concerned. Please do not expect me to visit your page to try and identify you/ your areas of work/ interest, etc. It is common courtesy to introduce oneself to another when interacting for the first time. I am merely requesting that the same civil courtesy be extended here, too. Henceforth, I may not accept any friend requests/ requests to join the group on facebook unless accompanied by a note of introduction (except when I already know the sender).  

Note 2. Please understand that this blog (and the corresponding facebook page/ group) is maintained in my spare time. I have a full time job, and am available to pursue these activities only after regular working hours (after 5 pm Indian Standard Time). However urgently you may wish to receive a response from me, I will be able to respond only upon returning home from work (I am offline the rest of the time).

Note 3. Please mind your language when interacting with me/ in the group linked to this blog. Rude/ offensive language will result in expulsion from both my friends list and the said group.

Enhanced by Zemanta

WHO releases World Malaria Report 2019 (4 December 2019)

The World Health Organization (WHO) has released World Malaria Report 2019.

Background Information:

In November 2018, WHO and the Roll Back Malaria (RBM) Partnership to End Malaria launched the high burden to high impact (HBHI) country-led approach as a mechanism to bring the 11 highest burden countries back on track to achieve the 2025 Global Technical Strategy (GTS) milestones.

This followed the results of the world malaria reports of 2017 and 2018, which showed that, globally, progress has stalled in high-burden countries and that the GTS 2020 milestones are, therefore, unlikely to be achieved. These 11 countries

  1. Burkina Faso,
  2. Cameroon,
  3. the Democratic Republic of the Congo,
  4. Ghana,
  5. India,
  6. Mali,
  7. Mozambique,
  8. Niger,
  9. Nigeria,
  10. Uganda and
  11. the United Republic of Tanzania

account for 70% of the global estimated case burden and 71% of global estimated deaths.

World Malaria Report 2019 HBHI 2019-12-05 20_07_02-World malaria report 2019 - Foxit Reader

Key Messages:

1. Trends in Regional and Global Burden of Cases and Deaths

A. Malaria cases

In 2018, an estimated 228 million cases of malaria occurred worldwide, compared with 251 million cases in 2010 and 231 million cases in 2017.

Most malaria cases in 2018 were in the World Health Organization (WHO) African Region (213 million or 93%), followed by the WHO South-East Asia Region with 3.4% of the cases and the WHO Eastern Mediterranean Region with 2.1%.

Nineteen countries in sub-Saharan Africa and India carried almost 85% of the global malaria burden. Six countries accounted for more than half of all malaria cases worldwide:

  • Nigeria (25%),
  • the Democratic Republic of the Congo (12%),
  • Uganda (5%), and
  • Côte d’Ivoire, Mozambique and Niger (4% each).

The incidence rate of malaria declined globally between 2010 and 2018, from 71 to 57 cases per 1000 population at risk. However, from 2014 to 2018, the rate of change slowed dramatically, reducing to 57 in 2014 and remaining at similar levels through to 2018.

The WHO South-East Asia Region continued to see its incidence rate fall – from 17 cases of the disease per 1000 population at risk in 2010 to five cases in 2018 (a 70% decrease). In the WHO African Region, case incidence levels also declined from 294 in 2010 to 229 in 2018, representing a 22% reduction. All other WHO regions recorded either little progress or an increase in incidence rate. The WHO Region of the Americas recorded a rise, largely due to increases in malaria transmission in the Bolivarian Republic of Venezuela.

Between 2015 and 2018, only 31 countries, where malaria is still endemic, reduced case incidence significantly and were on track to reduce incidence by 40% or more by 2020. Without accelerated change, the Global technical strategy for malaria 2016–2030 (GTS) milestones for morbidity in 2025 and 2030 will not be achieved.

Plasmodium falciparum is the most prevalent malaria parasite in the WHO African Region, accounting for 99.7% of estimated malaria cases in 2018, as well as in the WHO South-East Asia Region (50%), the WHO Eastern Mediterranean Region (71%) and the WHO Western Pacific Region (65%).

Globally, 53% of the P. vivax burden is in the WHO South-East Asia Region, with the majority being in India (47%). P. vivax is the predominant parasite in the WHO Region of the Americas, representing 75% of malaria cases.

B. Malaria deaths

In 2018, there were an estimated 405 000 deaths from malaria globally, compared with 416 000 estimated deaths in 2017, and 585 000 in 2010.

Children aged under 5 years are the most vulnerable group affected by malaria. In 2018, they accounted for 67% (272 000) of all malaria deaths worldwide.

The WHO African Region accounted for 94% of all malaria deaths in 2018. Although this region was home to the highest number of malaria deaths in 2018, it also accounted for 85% of the 180 000 fewer global malaria deaths reported in 2018 compared with 2010.

Nearly 85% of global malaria deaths in 2018 were concentrated in 20 countries in the WHO African Region and India; Nigeria accounted for almost 24% of all global malaria deaths, followed by the Democratic Republic of the Congo (11%), the United Republic of Tanzania (5%), and Angola, Mozambique and Niger (4% each).

World Malaria Report 2019 Country share of malaria cases and deaths 2019-12-05 20_00_53-World malaria report 2019 - Foxit Reader

In 2018, only the WHO African Region and the WHO South-East Asia Region showed reductions in malaria deaths compared with 2010. The WHO African Region had the largest absolute reduction in malaria deaths, from 533 000 in 2010 to 380 000 in 2018. Despite these gains, the malaria mortality reduction rate has also slowed since 2016.

2. Maternal, Infant and Child Health consequences of Malaria

In 2018, about 11 million pregnancies in moderate and high transmission sub-Saharan African countries would have been exposed to malaria infection.

In 2018, prevalence of exposure to malaria infection in pregnancy was highest in the West African subregion and Central Africa (each with 35%), followed by East and Southern Africa (20%). About 39% of these were in the Democratic Republic of the Congo and Nigeria.

The 11 million pregnant women exposed to malaria infections in 2018 delivered about
872 000 children with low birth weight (16% of all children with low birth weight in these countries), with West Africa having the highest prevalence of low birth weight children due to malaria in pregnancy.

Between 2015 and 2018 in 21 moderate to high malaria burden countries in the WHO African Region, the prevalence of anaemia in children under 5 years with a positive rapid diagnostic test (RDT) was double that of children with a negative RDT. In the children who were positive for malaria, 9% had severe anaemia and 54% had moderate anaemia; in contrast, in the children without malaria, only 1% had severe anaemia and 31% had moderate anaemia.

The countries with the highest percentage of severe anaemia among children aged under 5 years who were positive for malaria were Senegal (26%), Mali (16%), Guinea (14%) and Mozambique (12%). For most other countries, severe anaemia ranged from 5% to 10%.

Overall, about 24 million children were estimated to be infected with P. falciparum in 2018 in sub-Saharan Africa, and an estimated 1.8 million of them were likely to have severe anaemia.

3. High Burden to High Impact approach

There were about 155 million malaria cases in the 11 high burden to high impact (HBHI) countries in 2018, compared with 177 million in 2010. The Democratic Republic of the Congo and Nigeria accounted for 84 million (54%) of total cases.

Of the 10 highest burden countries in Africa, Ghana and Nigeria reported the highest absolute increases in cases of malaria in 2018 compared with 2017. The burden in 2018 was similar to that of 2017 in all other countries, apart from in Uganda and India, where there were reported reductions of 1.5 and 2.6 million malaria cases, respectively, in 2018 compared with 2017.

World Malaria Report 2019 Malaria cases in 7 states of India 2019-12-05 20_05_15-World malaria report 2019 - Foxit Reader

Malaria deaths reduced from about 400 000 in 2010 to about 260 000 in 2018, the largest reduction being in Nigeria, from almost 153 000 deaths in 2010 to about 95 000 deaths in 2018.

By 2018, in all of the 11 HBHI countries, at least 40% of the population at risk were sleeping under long-lasting insecticidal nets (LLINs), the highest percentage being in Uganda (80%) and the lowest in Nigeria (40%).

Only Burkina Faso and the United Republic of Tanzania were estimated as having more than half of pregnant women receiving three doses of intermittent preventive treatment in pregnancy (IPTp3) in 2018. In Cameroon, Nigeria and Uganda, the estimated coverage was about 30% or less.

Six countries in Africa’s Sahel subregion implemented seasonal malaria chemoprevention (SMC) in 2018; a mean total of 17 million children, out of the 26 million targeted, were treated per SMC cycle.

The percentage of children aged under 5 years with fever seeking treatment varied from 58% in Mali to 82% in Uganda. In the Democratic Republic of the Congo and Mali, more than 40% of children were not brought for care at all. Testing was also worryingly low in children who were brought for care, with 30% or less being tested in Cameroon, the Democratic Republic of the Congo and Nigeria.

Except for India, direct domestic investment remains very low relative to international funding in the HBHI countries.

Useful Links:

Link to the related WHO news release:


Link to World Malaria Report 2019: